"Durham Nephrology Associates is a medical group whose doctors, nurse practitioners, nurses and staff have been devoted to the welfare of patients for more than 30 years. We specialize in caring for people with kidney diseases and high blood pressure. Our goals include stopping or slowing the progression of an illness to prevent damage. Since some patients’ disease can worsen even with optimal medical care, we also devote ourselves to helping people physically and mentally prepare for the possibility of future dialysis treatments and transplantation. We also help with long term dialysis and transplantation needs. Patients can be cared for at our Durham and Oxford offices and we also staff a Kidney Clinic at Lincoln Community Health Center."

During the past decade, Durham Nephrology Associates conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Durham Nephrology Associates" #1 sponsor was "Trevi Therapeutics" with 2 trials, followed by "Ardelyx" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Christopher Granger, MD" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Durham Nephrology Associates" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Durham Nephrology Associates" are "Pruritus" (2 trials), "Uremic Pruritus" (2 trials), "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease (CKD)" (1 trials) and "End Stage Renal Disease" (1 trials). Many other conditions were trialed in "Durham Nephrology Associates" in a lesser frequency.

Most popular intervention types in "Durham Nephrology Associates" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BAY1213790 (Osocimab)" (1 trials), "Epoetin Hospira Arm" (1 trials), "IV Iron" (1 trials) and "Phosphate Binder Agents" (1 trials). Other intervention names were less common.

The vast majority of trials in "Durham Nephrology Associates" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Durham Nephrology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Durham Nephrology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Durham Nephrology Associates, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".